✦ LIBER ✦

5-aminosalicylic acid preparations in the treatment of inflammatory bowel disease

✍ Scribed by G. F. Bonner; W. B. Ruderman

Book ID: 110609821
Publisher: Springer
Year: 1993
Tongue: English
Weight: 991 KB
Volume: 2
Category: Article
ISSN: 0925-4692
DOI: 10.1007/bf02660616

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

REVIEW: Role of 5-Aminosalicylic Acid (5

REVIEW: Role of 5-Aminosalicylic Acid (5-ASA) in Treatment of Inflammatory Bowel Disease: A Systemic Review

✍ Javier P. Gisbert; Fernando Gomollón; José Maté; José María Pajares 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 115 KB

Cancer prevention in inflammatory bowel

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid

✍ Dr. Charles N. Bernstein; Jayne Eaden; A. Hillary Steinhart; Pia Munkholm; Phili 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

5-aminosalicylates in inflammatory bowel

5-aminosalicylates in inflammatory bowel disease and chronic renal failure

✍ F. Tekin; O. Ozutemiz; T. Ilter 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Tolerance of 4-aminosalicylic acid enema

Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic–induced acute pancreatitis

✍ Fady Daniel; Philippe Seksik; Wulfran Cacheux; Raymond Jian; Philippe Marteau 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Clinical tolerance to three 5-aminosalic

Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine

✍ M. H. GIAFFER; C. J. O'BRIEN; C. D. HOLDSWORTH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

5-Aminosalicylates and renal function in

5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review

✍ Javier P. Gisbert; Yago González-Lama; José Maté 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Nephrotoxicity has been described in some patients with inflammatory bowel disease (IBD) treated with 5-aminosalicylic acid (5-ASA). Studies with 5-ASA treatment in which serum creatinine or creatinine clearance was measured regularly show that nephrotoxicity is exceptional (mean rate of only 0.26%